The emerging approach of the medication represents a major advance in the management of diabetes mellitus type 2. Different to existing drugs, tirzepatide affects two pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatide-peptide335559.blogadvize.com/50608838/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment